While several TRPV1 agonists or antagonists have demonstrated improved efficacy in pre‐clinical and clinical trials for arthritis pain, attention needs to be given to adverse reactions, such as drug‐induced increases in core body temperature. This evidence concerns the gene TRPV1 and Arthritis.